Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07897058

Project E-Shift: A Harm Reduction Intervention for Chronically Unhoused Smokers.

Conditions: Cigarette Smoking Behavior, E-Cigarette Use

Sex: All
Ages: 21 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 44
Sponsor: Thomas Jefferson University

Location: Pathways to Housing Philadelphia Pennsylvania

Summary

This pilot randomized trial tested whether switching to e-cigarettes, compared with standard nicotine replacement therapy (NRT; patch and gum), helped adults with a history of chronic homelessness stop smoking combustible cigarettes. All participants received brief cessation counseling and incentives for carbon monoxide (CO)-verified abstinence from cigarettes during the first weeks after a scheduled switch date. Participants were followed for 12 weeks after switching, with a final follow-up at 24 weeks. The study also assessed feasibility (recruitment, retention, and visit attendance) and used interviews with participants and service-agency staff to understand acceptability and how a tobacco harm reduction program could fit into existing housing and clinic services.

Eligibility Criteria

Inclusion Criteria: * Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study: * Provide signed and dated informed consent form * Willing to comply with all study procedures and be available for the duration of the study. * Male or female aged 21 and above. * expired CO \>6 ppm at screening * People of reproductive potential must not be pregnant nor trying to become pregnant. * Adequate literacy to complete self-administered study questionnaires, defined as a score ≥4 out of 7 on the Rapid Estimate of Adult Literacy in Medicine - Short Form (REALM-SF), corresponding to a 7th-grade reading level or higher Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in this study: * Anyone who has trouble understanding the consent or with significant anxiety detected during the consent process will also be excluded. * Medical condition that precludes participation * Current use of THC-containing vaping products * Pregnancy or lactation * Known allergic reactions to components of the study product(s) * Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07897058). StuddyBuddy aggregates publicly available trial information.